top of page

The complex art of translating discovery into therapy – an international perspective

Best international strategies to support a successful translation of discovery into therapy.

Julia Schaft (BioRN) and André H.R. Domin (Heidelberg Startup Partners and Technology Park Heidelberg) opening the event. Source: BioRN

Heidelberg, 22 October. Technology transfer from academia to industry is an important part of health innovation. However, the interplay between research institutions, startups, venture capitalists, and pharmaceutical companies is an intricate process.

International key opinion leaders involved in the technology transfer process met yesterday in Heidelberg during an afterwork panel discussion. The regional life science research and industry cluster, BioRN and the joint startup initiative of Heidelbergs’ leading research and educational institutes, Heidelberg Startup Partners jointly organised the event to address this complex process, discuss best-practices and new ideas.

Christina Takke (V-Bio Ventures, Belgium), Joern-Peter Halle (Merck Healthcare KGaA), Phil Elstob (Cambridge Enterprise, UK) and Andreas Jenne (serial entrepreneur and now RSP System) have been invited to share their views, hurdles and success stories at the event. As key players representatives of the technology transfer value chain, they vividly engaged in a constructive discussion, underlining the need of dialog and joint effort between the parties.

“Technology Transfer is obviously an important and challenging activity that only succeeds when all involved partners actively support each other. To further improve, we should join forces at all levels to develop new partnership models and try them out.” commented Jürgen Bauer (EMBLEM and Heidelberg Startup Partners Board Member), who joint the panel discussion as regional technology transfer office representative.

The event attracted about 50 scientists and professionals, representing the whole spectrum of the life science innovation ecosystem dealing at different point with the technology transfer process.

Siegfried Bialojan (E&Y and BioRN Strategic Board Member) who moderated the event, said “It is a clear signal, that the region not only recognizes its enormous potential in Life Sciences, but now also really joins forces to put translation into practice. This event is part of it – involving all relevant players as well as learning from and discussing best practice with others is a perfect start.”

Source: BioRN and Heidelberg Stratup Partners

BioRN is the science and industry cluster of the Rhine-Main-Neckar region around Heidelberg, one of Germany’s strongest biotech hubs. It is a non-profit network fostering health innovations and serving its members by creating a rich translational ecosystem as well as promoting, representing and connecting the regional innovation stakeholders.

Our vision is to develop the region into a world-leading life science cluster attracting international investments and top global talent.

BioRN has more than 100 institutional members, including the top academic and research institutions, 7 global pharmaceutical companies, a large range of small and medium-sized enterprises bolstering the life science ecosystem as well as local government organizations and interest groups.

Heidelberg Startup Partners is a joint initiative of Heidelberg's leading institutes for research, education, and economic promotion. Its members include the EMBL Enterprise Management, German Cancer Research Center (DKFZ), Heidelberg Technology Park, Heidelberg University, Heidelberg University of Education, IHK Rhein-Neckar, Innovation Lab, SRH University Heidelberg, and technology transfer heidelberg. The association aims to promote startups in the technology and knowledge-based fields in the greater Heidelberg area. For this purpose, the Heidelberg Startup Partners maintain a startup office which acts as a central contact point for people interested in setting up a business and founders from the participating institutions. The offer includes individual consultation, accelerator programs, various networking events, as well as access to an international network of industry experts and investors.


Os comentários foram desativados.
bottom of page